Vetter Pharma International dedicated its new 24,000-sq.-ft. facility at the Illinois Science + Technology Park in Skokie, IL on Dec. 1. The new facility will focus exclusively on preclinical through Phase IIb projects and will fill very small quantities of product, required for early studies. Phase III projects will be transferred to the company’s German facilities for large-scale production. The Skokie site is expected to be operational by the end of 2010. “For injectable drugs, collaborati...